Covance announces it has entered into a definitive agreement with Merck & Co, Inc. relating to the supply of genomic analysis services.
A new urine test developed with funding from the Wellcome Trust will allow doctors to diagnose chlamydia infection in men within the hour.
Ovarian malignancies are a leading cause of cancer death in women because they are usually detected in the late stages when the disease is incurable. Encouraging new research presented by Abbott shows that a novel diagnostic marker, combined with other tests, can be used to more effectively monitor for early-stage ovarian cancer.
Michael Cobble, MD, director of Canyons Medical Center in Sandy, Utah, has been appointed as Chief Medical Officer of Atherotech Inc.
HHS Secretary Kathleen Sebelius today announced the availability of $200 million to support grants, loans, loan repayment, and scholarships to expand the training of health care professionals. The funds are expected to train approximately 8,000 students and credentialed health professionals by the end of fiscal year 2010.
In the race for faster, cheaper ways to read human genomes, Pacific Biosciences is hoping to set a new benchmark with technology that watches DNA being copied in real time.
Senate Majority Leader Harry Reid (D-Nev) has conceded that the Senate will not pass a health care reform bill before the August Congressional recess. Meanwhile, House officials have not ruled out a special session that would spill over into the heart of Summer.
MP Biomedicals LLC launched its FASTSURE DNA Rapid Test range with the introduction of FASTSURE TB DNA Rapid Test.
Agilent Technologies Inc and Varian Inc today announced that they have signed a definitive agreement for the acquisition by Agilent of Varian, a worldwide supplier of scientific instrumentation and associated consumables for life science and applied market applications.
Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study.